trending Market Intelligence /marketintelligence/en/news-insights/trending/WXm2Cbbp6BMO6YvKvepR3A2 content esgSubNav
In This List

Relevium cancels equity purchase in CannaKids, enters license deal instead

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


Relevium cancels equity purchase in CannaKids, enters license deal instead

Relevium Technologies Inc. said it is no longer acquiring an equity stake in CK Properties and its CannaKids brand under a previous deal.

CK Properties develops medical cannabis for pediatric and adult applications. Relevium previously agreed to acquire an initial 25% of the outstanding shares of CK Properties and CannaKids and the Canadian exclusive rights for the brand for US$2.7 million.

Instead, the Montreal-based healthcare equipment company will buy an exclusive license for the CannaKids intellectual property in Canada for $1.1 million. The renegotiated deal consideration includes $800,000 in shares and $300,000 in cash.

CK Properties will also be eligible for a 13% royalty on sales under the renegotiated license deal.

Relevium expects the transaction to close upon approval by the TSX Venture Exchange.